ArticleBiomolecules & biomedicine2025

Impact of thyroid immune-related adverse events on clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with checkpoint inhibitor therapy: A single center study.

Šejla Cerić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.